Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a pseudogene related to kinesin family member 27 (KIF27), which means it is a DNA sequence similar to a protein-coding gene but lacks the ability to encode a functional protein. Pseudogenes arise from gene duplication or retrotransposition events but accumulate mutations rendering them nonfunctional. This pseudogene is annotated in genomic databases, but unlike the functional KIF27, which is involved in microtubule-based motor activity and ciliogenesis, the pseudogene does not have a direct biological role or known disease relevance[3][7]. Its designation as "target" is likely incorrect, as pseudogenes are typically not considered therapeutic targets.\n\nKey clarifications:\n- The ENSG00000165121 identifier provided in the query does not map to the KIF27 pseudogene (or to any gene in current Ensembl); the recognized KIF27 pseudogene is annotated as ENSG00000234424 in Ensembl[3].\n- KIF27 (the protein-coding gene) is a member of the kinesin superfamily involved in ciliary function and Hedgehog signaling; the pseudogene does not participate in these functions[1][9].\n- No evidence exists for this specific pseudogene being a direct or indirect therapeutic target in any context.\n\nSummary for disambiguation:\nIf you intended to reference the functional Kinesin family member 27 (KIF27, ENSG00000165115)—a genuine molecular target—please clarify. The information above exclusively refers to the pseudogene as requested in your query, which is not functionally relevant for therapeutic or biomarker applications[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinesin family member 27 pseudogene.